Effect of sodium-glucose transporter 2 inhibitors on sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis

OBJECTIVE: Sarcopenia has been recognized as the third category of disabling complications in patients with type 2 diabetes mellitus(T2DM), in addition to micro- and macrovascular complications. Sodium-glucose co-transporter 2 (SGLT2) inhibitors are innovative glucose-lowering treatments that have b...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Sha, Qi, Zhan, Wang, Yidong, Song, Danfei, Zhu, Deqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351980/
https://www.ncbi.nlm.nih.gov/pubmed/37465122
http://dx.doi.org/10.3389/fendo.2023.1203666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351980/
https://www.ncbi.nlm.nih.gov/pubmed/37465122
http://dx.doi.org/10.3389/fendo.2023.1203666

Ejemplares similares